Get the Stockscreener App
3.31
1.22%
0.04
Dna X Inc stock is traded at $3.31, with a volume of 6,680.
It is up +1.22% in the last 24 hours and down -4.34% over the past month.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
See More
Previous Close:
$3.27
Open:
$3.26
24h Volume:
6,680
Relative Volume:
0.67
Market Cap:
$4.93M
Revenue:
$27.40M
Net Income/Loss:
$-17.12M
P/E Ratio:
-0.031
EPS:
-106.8896
Net Cash Flow:
$-24.99M
1W Performance:
-6.89%
1M Performance:
-4.34%
6M Performance:
+10.33%
1Y Performance:
-77.27%
1-Day Range:
$3.26
$3.42
1-Week Range:
$3.10
$3.74
52-Week Range:
$2.5211
$16.97
Dna X Inc Stock (SONM) Company Profile
Name
Dna X Inc
Sector
Industry
Phone
650-378-8100
Address
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MS, GS, SCHW, HOOD, IBKR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.31 | 4.93M | 27.40M | -17.12M | -24.99M | -106.89 |
MS
Morgan Stanley
|
178.47 | 280.30B | 128.77B | 20.37B | 39.02B | 12.37 |
GS
Goldman Sachs Group Inc
|
875.78 | 255.00B | 128.57B | 20.97B | 112.72B | 64.79 |
SCHW
Charles Schwab Corp
|
89.58 | 154.91B | 28.33B | 9.42B | 9.76B | 5.0426 |
HOOD
Robinhood Markets Inc
|
96.52 | 86.78B | 4.65B | 1.89B | -2.09B | 2.0676 |
IBKR
Interactive Brokers Group Inc
|
81.35 | 36.86B | 10.76B | 4.56B | 35.82B | 2.326 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-19 | Initiated | B. Riley FBR | Buy |
| Jul-09-19 | Upgrade | National Securities | Neutral → Buy |
| Jun-10-19 | Initiated | National Securities | Neutral |
| Jun-04-19 | Initiated | Lake Street | Buy |
| Jun-04-19 | Initiated | Oppenheimer | Outperform |
View All
Dna X Inc Stock (SONM) Latest News
SONM 8-K & SEC Filings - Yahoo Finance Australia
SONM 8-K/A & SEC Filings - Yahoo Finance Australia
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
DNA X, Inc.: Dividend historical data and projections - www.marketscreener.com
DNAGinkgo Bioworks Holdings Inc. | News - OTC Markets
A planned share sale leaves Ginkgo Bioworks (DNA) CFO holding 49,448 shares directly. - Stock Titan
Applied DNA Sciences, Inc. (OTC: BNBX) Share Price, BNBX Stock News, BNBX Share Price & Updates - Kalkine
AIxCrypto Holdings, Inc. (AIXC) stock price, news, quote and history - Yahoo Finance UK
Scribe Therapeutics Inc. Common Stock (NASDAQ: SCTX) Stock Price, News & Analysis - kalkine.ca
VEON Ltd. (VEON) stock price, news, quote and history - uk.finance.yahoo.com
VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada
VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance Singapore
Ginkgo Bioworks (NYSE: DNA) director sells 5,000 shares near $7.08 - Stock Titan
Director plans potential 5,000-share sale at Ginkgo Bioworks (NYSE: DNA) - Stock Titan
Ginkgo Bioworks Holdings (NYSE:DNA) Stock Forecast & Analyst Predictions - Simply Wall Street
Press Release Service: Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform - CRISPR Medicine News
Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period - The Globe and Mail
DNA regained Nasdaq equity compliance but faces one-year mandatory monitor - TradingView
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Profit Recovery Report - vinanet.vn
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Management Guidance Update - careplusvn.com
Sonim Technologies Adopts Cash-Based Director Compensation Structure - The Globe and Mail
DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView
DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan
SONM 8-K & SEC Filings - Yahoo Finance Australia
Ginkgo Bioworks (DNA) CFO logs 743 RSU vesting, tax sale - Stock Titan
Ginkgo Bioworks (DNA) officer to sell 330 shares for taxes after vesting - Stock Titan
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade
DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView
SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView
DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan
DNA X: Q2 Earnings Snapshot - marketscreener.com
DNA X: Q2 Earnings Snapshot - AOL.com
DNA X: Q2 Earnings Snapshot - KTVB
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
C&F Financial Corporation Announces Quarterly Dividend - The Manila Times
Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times
VVC Exploration Corporation Files Annual Financial Statements - The Manila Times
DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan
DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn
DNA X Inc: Expects Revenue From Trading Platf - Moomoo
DNA X, Inc. Reports Second Quarter 2026 Financial Results - Yahoo Finance
12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga
Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - vinanet.vn
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st
Sonim Technologies delays quarterly filing amid consolidation - TipRanks
DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
META_TITLE_QUOTE - Yahoo Finance
DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan
Dna X Inc Stock (SONM) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.51%
6.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):